Indocyanine Green for Central Nervous System Tumors
Status:
Completed
Trial end date:
2020-04-02
Target enrollment:
Participant gender:
Summary
This study is a single center, open-label, two-part study to assess image guided surgery of
intramolecular imaging in nervous system tumors. Subjects with a diagnosis of a resectable
nervous system tumor who are at risk of recurrence are included. The primary goal is to
observe what tissues fluoresce in the OR, and then to identify if that tissue is
cancerous/tumor or normal when the histopathology is performed.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania